DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/d2d073/italian_hemostais) has announced the addition of the "Italian Hemostais Market" report to their offering.
This comprehensive country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the hemostasis diagnostics market during this decade.
The report explores business and technological trend; provides estimates of the test volume, instrument placements and installed base, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next ten years.
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the hemostasis diagnostics practice during the next ten years.
New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Hemostasis testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the hemostasis testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
Each Country Report provides the following information:
- Sales and market shares of major instrument and reagent suppliers.
- Strategic profiles of leading competitors and emerging market entrants.
- Comprehensive market segmentation analysis.
- Forecasts for over 40 procedures, by country and market segment.
- Review of emerging tests.
- Comparison of over 50 automated and semi-automated analyzers.
- Analysis of innovative technologies.
- Estimates of facilities performing hemostasis tests by country.
- Product development and business expansion opportunities.
- Alternative market penetration strategies.
Highlights:
- Comprehensive 402-page analysis of the Italian hemostasis market.
- Major issues pertaining to the Italian hemostasis laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Ten-year volume and sales forecasts for 40 hemostasis procedures performed in Italian hospitals and commercial laboratories, including typical hemostasis daily work loads.
- Placement estimates for major automated and semi-automated systems.
- Review of current instrumentation technologies, and a feature comparison of nearly 50 leading analyzers.
- Ten-year reagent and instrument sales forecasts.
- Sales and market shares of leading reagent and instrument suppliers.
- Review of hemostasis technologies and their potential market applications.
- Major opportunities for hemostasis instruments and consumables.
- Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Business opportunities and strategic recommendations for instrument and reagent suppliers.
Contains 402 pages and 16 tables
Companies Mentioned:
- Abbott
- American Diagnostica
- Avocet Medical
- Axis-Shield
- Beckman Coulter
- Becton Dickinson
- Bio/Data Corporation
- Biosite
- Chrono-Log
- Corgenix Medical
- Diagnostica Stago
- Helena Laboratories
- HYPEN BioMed
- Instrumentation Laboratory
- ITC
- Nanogen
- Roche
- Siemens
- Sienco
- Sysmex
- Thermo Fischer
- Trinity Biotech
- ZyCare
For more information visit http://www.researchandmarkets.com/research/d2d073/italian_hemostais